Overall, these data indicate that PKM2 endows T cells with metabolic flexibility to increase aerobic glycolysis when mitochondrial metabolism is limited, as is often the case in hypoxic tumor microenvironments [55]. This evidence concerns the gene PKM and neoplasm.